A Study to Evaluate the Safe and Effective Use of a Zilucoplan Auto-injector by Study Participants With Generalized Myasthenia Gravis
Clinical trial NCT06471361 · COMPLETED
Trial details
- NCT number
- NCT06471361
- Sponsor
- UCB Biopharma SRL
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-27
- Primary completion
- 2025-01-28
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.